Achievements

Since 2007, the percentage of patients acquiring Bioness technologies through reimbursement has increased by over 25%.

Since 2009, individuals with Incomplete Spinal Cord Injury have been eligible for device coverage through Medicare.

Our collective efforts and advocacy are making a difference!

Clinical Data for Bioness Rehabilitation Systems

Research Shows the Effectiveness of This Revolutionary Technology

Technological Advances in Stroke Rehabilitation – High Tech Marries High Touch

Functional Electrical Stimulation (FES)

Neurologist, Richard C. Senelick, MD writes about the benefits of Functional Electrical Stimulation (FES) to restore and improve functional abilities in the latest publication of US Neurology entitled, “Technological Advances in Stroke Rehabilitation – High Tech Marries High Touch”.

Read the full article here

Studies Show the Benefits of FES and the H200 System

An acute stroke study by Alon showed that a 12-week task-specific training protocol incorporating FES resulted in better functional recovery of the upper extremity in stroke survivors with mild to moderate paresis than task-specific training alone1.

  • Individuals reported a significant decrease in tone in the elbow and wrist
  • Statistically significant improvements were seen in selected hand function: simulated feeding time (34.8%), Light Object Lift time (44.9%), Heavy Object Lift time (40.9%), and time to complete the 9-Hole Peg Test (58.7%)
H200 Hand Rehabilitation System Data

Clinical Evidence Suggests Significant Improvements in Hand Function and Daily Activities with the H200 System

A sub-acute stroke study by Ring assessed the use of the H200 System in daily therapy and showed significantly improved outcomes vs. a control group.

Ring and Colleagues Findings3:

  • A six-week home-based H200 program resulted in significantly greater improvements in reduction of muscle spasms throughout the upper extremity and active range of motion in the shoulder and wrist
  • In individuals with partial active motion of the hand, greater functional recovery of the upper extremity was demonstrated by statistically significant differences in all 4 functional hand tests
  • All individuals that reported edema at onset in the H200 group demonstrated improvements
Type II Patient Outcomes

References:
1. Alon G, et al. 2007 Neurorehabil Neur Repair. 21(3)207-215.
2. Ring H, et. al. 2005. J Rehabil Med. 37:32-36.
3. Ring H, et. al. 2005. J Rehabil Med. 37:32-36.

L300 Data

A recent research study showed the L300 Foot Drop System may increase walking speed, improve stability, lower the incidence of falling and provide more confidence.1 Another study2 showed that the system offers significant improvements when compared to walking without it.

The results speak for themselves (walking with the L300 Food Drop System vs. without):

  • 17% increase in average walking speed
  • 34% increase in average walking speed after 8 weeks
  • 45% improvement in gait symmetry index after 8 weeks
  • 33% improvement in stride time variability after 8 weeks (a marker of gait stability and fall risk)
  • Fall frequency decreased by 92%
L300 Foot Drop System Data

Chronic Stroke L300 Study2

Neuroprosthetic Benefit

24 patients with chronic hemiparesis (5.8 ± 5.2 yrs post) participated in an 8 week study using the L300 Foot Drop System

Chronic Stroke L300 Study

References:
1. Hausdorff JM, Ring H. 2006. The effect of a new lower-limb neuroprosthesis on physical and social functioning. J Neurol Phys Ther. 30(4):207.
2. Hausdorff JM, Ring H. 2008. Effects of a new radio frequency-controlled neuroprosthesis on gait symmetry and rhythmicity in patients with chronic hemiparesis. Am J Phys Med Rehabil. 87(1):4-13.

New Research

  • A 42-week study looking at the impact of the L300 Foot Drop System on sub-acute and chronic stroke was recently completed and is scheduled to be published early in 2014.. 
  • The complete 30-week paper published in STROKE can be found HERE
  • The results are compelling as the comfortable and fast walking speed increased 33% from baseline through 30-weeks. Patients achieved not only an orthotic effect but therapeutic carryover (motor relearning) as their walking speed increased when the L300 was removed.